# NeuraLace Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuralace-medical

- Industry: Medical Devices & Equipment
- Headquarters: San Diego, US
- Website: www.neuralacemedical.com
- Total disclosed funding: $5M
- Latest round: Seed (Jun 18, 2019)
- Investors on record: 5

## About

NeuraLace Medical, Inc. specializes in non-invasive treatments for chronic neuropathic pain using innovative magnetic Peripheral Nerve Stimulation technology, offering an alternative to traditional pain management methods.Founded in 2016 by Shiv Shukla, NeuraLace Medical, Inc. is headquartered in San Diego, US. The company focuses on developing advanced therapies for pain management, having pivoted from initial concepts to a specialized device targeting chronic nerve pain. The firm has secured a total of USD 3.000 mn through 3 funding deals, with the latest being a SEED round in June 2019, led by Mesa Verde Venture Partners and supported by FusionX Ventures, MooDoos Limited Partnership, and Teal Ventures.NeuraLace Medical primarily offers Axon Therapy® mPNS, a non-invasive treatment device designed for the management of chronic neuropathic pain. This platform utilizes magnetic Peripheral Nerve Stimulation (mPNS) technology to deliver high-intensity magnetic pulses that engage sensory, pain, and motor fibers. The device aims to alleviate chronic nerve pain without the need for invasive procedures, targeting healthcare providers and pain management specialists in the US and select European regions.NeuraLace Medical generates revenue through the direct sale of Axon Therapy® mPNS devices to healthcare facilities and pain management clinics. The company operates on a B2B model, with transactions typically involving healthcare providers purchasing the mPNS device for their practices, supplemented by potential service agreements for ongoing support.NeuraLace Medical is focused on expanding its market presence and product offerings. Following the recent SEED funding of USD 3.000 mn raised in June 2019, the company plans to enhance its technology and explore new geographic markets, particularly in Europe, by 2021. This funding will facilitate the development of upcoming products targeting broader pain management solutions.

## Funding rounds

- Seed, Jun 18, 2019, $3M — Mesa Verde Venture Partners, MooDoos Limited Partnership, FusionX Ventures, Teal Ventures
- Seed, Mar 15, 2017, $2M — FusionX Ventures, Mooring Ventures

## Investors

- FusionX Ventures (https://capitalatlas.ai/funds/fusionx-ventures) — Seed
- Mooring Ventures (https://capitalatlas.ai/funds/mooring-ventures) — Seed
- Mesa Verde Venture Partners (https://capitalatlas.ai/funds/mesa-verde-venture-partners) — Seed
- MooDoos Limited Partnership — Seed
- Teal Ventures (https://capitalatlas.ai/funds/teal-ventures) — Seed